In summary, these studies indicate a protective role of ATII specific PFKFB3 by promoting glycolytic responses during ALI and lay the groundwork for ARDS treatment approaches using glycolytic intermediates, such as pyruvate. Here, PFKFB3 is linked to acute respiratory distress syndrome.